Stephen Rulisa
Prof Stephen Rulisa, MD, FCOG(ECSA) is an expert in Obstetrics at University of Rwanda (Rwanda). As of October 2026, ScienceLeadR ranks Stephen Rulisa in the top 1% of experts in Rwanda for Epidemiologic Studies. Stephen Rulisa has authored 166 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 456 (community average: 125). How the SLR is computed.
LeadR Profile
Obstetrics
Subspecialties: Public Health - Gynecology - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Prof. Stephen Rulisa MD, FCOG(ECSA), PhD is a distinguished Professor of Obstetrics and Gynecology and Researcher at the University of Rwanda and a Chief Consultant at the University Teaching Hospital of Kigali (CHUK). He is widely recognized as a leading voice in maternal health, infectious disease epidemiology, and medical education in Africa. He is a widely published researcher.
Previously served as Dean of the School of Medicine and Pharmacy, Head of Obstetrics and Gynecology at the University of Rwanda, founding chair of the Education and Clinical Research department at CHUK, and President of the Rwanda Medical Association.
He holds key international and regional roles including Trustee for Africa & Eastern Mediterranean at FIGO and Chair of the ECSACOG Education, Scientific, and Research Committee. Nationally, he chairs Rwanda's MPDSR committee and serves on other international roles including being Senior Technical advisor for MNCNH at Gates Foundation.
Organizations
Career arc: 2008 - 2026
Number : 166
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Barriers and Opportunities in Therapeutic Development for Early-Onset Preeclampsia. PMID 42935470 — drug development, safety, pre-eclampsia, uncertainty, biomarkers, therapeutics, hemodynamics | Hypertension | 2026 | 0 |
| Exploring the Social and Financial Impacts of Cervical Cancer on Caregivers in Low- and Middle-Income Countries: A Scoping Review. PMID 42920353 — uterine cervical neoplasms, caregivers, neoplasms, income, employment, education | Psychooncology | 2026 | 0 |
| Evaluating the feasibility of using SMS to recruit women for cervical cancer screening in Rwanda: A pilot study. PMID 42479948 — pilot projects, pilots, global health, uterine cervical neoplasms, neoplasms, obstetrics, digital health | Int J Gynaecol Obstet | 2026 | 0 |
| Prevention of postpartum haemorrhage: from evidence to implementation at scale. PMID 42285117 — pregnancy, parturition, anemia, pharmaceutical preparations, oxytocin, ergonovine, therapeutics, misoprostol, postpartum period | Lancet Top journal | 2026 | 4 |
| Sexual function and wellbeing of women using modern contraceptive methods in Rwanda: a multicenter cross-sectional study. PMID 41756537 — cross-sectional studies, family planning services, contraception, reproductive health, intrauterine devices, contraceptive agents | Front Glob Womens Health | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation NCT07661433 — research design, pregnancy, parturition, fetal weight, ultrasonography, biometry, machine learning, deep learning, birth weight, learning | N/A | Recruiting | 2026 |
LeadR Networks
Main global connection map